AcelRx Pharmaceuticals, Inc.
(NASDAQ : ACRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. 3.03%61.940.0%$779.50m
VRXValeant Pharmaceuticals International, Inc. -2.07%28.8614.1%$169.82m
CTLTCatalent, Inc. 0.28%141.412.0%$168.28m
PRGOPerrigo Co. Plc 0.55%43.016.9%$140.02m
ICLRICON plc 0.56%283.042.8%$122.12m
HZNPHorizon Therapeutics Plc 0.80%110.375.5%$106.97m
JAZZJazz Pharmaceuticals Plc 0.63%135.352.1%$104.94m
INDPIndaptus Therapeutics, Inc. -6.86%8.820.0%$101.49m
ARGXargenx SE -3.15%308.000.0%$64.03m
BHCBausch Health Cos., Inc. -2.07%28.860.0%$60.89m
ENDPEndo International Plc -3.85%3.258.5%$56.03m
UTHRUnited Therapeutics Corp. -2.68%195.1014.0%$46.59m
AXSMAxsome Therapeutics, Inc. 1.34%33.401.8%$38.98m
IRWDIronwood Pharmaceuticals, Inc. 3.54%13.459.5%$24.56m
SAGESAGE Therapeutics, Inc. -1.69%45.427.6%$21.56m

Company Profile

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.